Login to Your Account

VBI, Scivac enter home stretch on merger, look to synergistic boost

By Marie Powers
News Editor

Thursday, April 14, 2016

With a declaration by the SEC that the registration statement filed by Scivac Therapeutics Inc. on its proposed merger with VBI Vaccines Inc. was effective, the companies are moving to complete the deal, expected early next month after VBI stockholders meet on May 5 to vote on the transaction.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription